USEFULNESS OF GRANULOCYTE COUNT MEASUREMENT 4 HOURS AFTER INJECTION OF GRANULOCYTE-COLONY-STIMULATING FACTOR FOR DETECTING RECOVERY FROM ANTITHYROID DRUG-INDUCED GRANULOCYTOPENIA
J. Tajiri et al., USEFULNESS OF GRANULOCYTE COUNT MEASUREMENT 4 HOURS AFTER INJECTION OF GRANULOCYTE-COLONY-STIMULATING FACTOR FOR DETECTING RECOVERY FROM ANTITHYROID DRUG-INDUCED GRANULOCYTOPENIA, Thyroid, 7(4), 1997, pp. 575-578
This prospective study was designed to investigate the usefulness of g
ranulocyte count measurements 4 hours after injection of granulocyte c
olony-stimulating factor (G-CSF) for detecting recovery from antithyro
id drug (ATD)-induced granulocytopenia or agranulocytosis. Granulocyte
and white blood cell counts were measured 4 hours and 24 hours after
patients with ATD-induced granulocytopenia had been given an injection
of 75 mu g of G-CSF (1.1 to 1.9 mu g/kg; 1.5 +/- 0.2 mu g/kg [mean +/
- standard deviation]). Thirty-seven patients were studied and divided
into three groups based on their initial granulocytopenic granulocyte
count: 28 with mild (granulocyte count 0.501 to 1.0 x 10(9)/L), 6 wit
h moderate (granulocyte count 0.101 to 0.5 x 10(9)/L), and 3 with seve
re (granulocyte count less than 0.1 x 10(9)/L) ATD-induced granulocyto
penia. Twenty-five of the 28 patients with mild granulocytopenia and 4
of the 6 patients with moderate granulocytopenia were found to have r
ecovered from the granulocytopenia both 4 hours and 24 hours after inj
ection, and their granulocyte counts remained normal thereafter. Howev
er, the other 3 patients with mild granulocytopenia, 2 patients with m
oderate granulocytopenia, and all 3 patients with severe granulocytope
nia had not recovered by either 4 or 24 hours after the G-CSF injectio
n. Despite daily C-CSF injections, the granulocyte continued to decrea
se in most cases. It took 2 to 11 days for these counts to recover fro
m granulocytopenia. These results indicate that granulocyte count meas
urement 4 hours after injection of G-CSF is useful for detecting recov
ery from ATD-induced granulocytopenia or agranulocytosis and for predi
cting disease severity. Accordingly, its measurement enables physician
s to make an appropriate decision about whether a patient with ATD-ind
uced granulocytopenia should be treated in the hospital or in the outp
atient clinic.